Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2a, Open-Label Pilot Study to Evaluate the Safety/Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of VTX2735 in Participants With Recurrent Pericarditis

NCT06836232 is registered in ClinicalTrials.gov with Zomagen Biosciences Ltd. as lead sponsor.

NCT NCT06836232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06836232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2a, Open-Label Pilot Study to Evaluate the Safety/Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of VTX2735 in Participants With Recurrent Pericarditis
Lead sponsor
Zomagen Biosciences Ltd.
Phase
Phase 2
Overall status
Recruiting
Start date
January 28, 2025
Completion date
October 31, 2027
Enrollment
50 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent pericarditis